⌘K

Login Start Free

Home/Filings/4/0001127602-23-009228

4//SEC Filing

PENDARVIS DAVID 4

Accession 0001127602-23-009228

CIK 0000943819other

View on SEC.gov Company Profile

Filed

Mar 6, 7:00 PM ET

Accepted

Mar 7, 12:32 PM ET

Size

4.3 KB

Accession

0001127602-23-009228

Insider Transaction Report

Form 4

Period: 2023-03-03

PENDARVIS DAVID

Sr. VP, General Counsel

Transactions

Sale
ResMed Common Stock
2023-03-03$216.69/sh−1,500$325,035→ 94,172 total

Footnotes (1)

[F1]The transaction was conducted under a Rule 10b5-1 plan adopted November 29, 2022.

Documents

1 file

4
form4.xmlPrimary
PRIMARY DOCUMENT

Issuer

RESMED INC

CIK 0000943819

Entity typeother

Related Parties

1

filerCIK 0001196723

Filing Metadata

Form type: 4
Filed: Mar 6, 7:00 PM ET
Accepted: Mar 7, 12:32 PM ET
Size: 4.3 KB

View on SEC.gov